Cargando…

Drug Resistance and Novel Therapies in Cancers

Detalles Bibliográficos
Autor principal: Wang, Zhixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601148/
https://www.ncbi.nlm.nih.gov/pubmed/33053621
http://dx.doi.org/10.3390/cancers12102929
_version_ 1783603334708461568
author Wang, Zhixiang
author_facet Wang, Zhixiang
author_sort Wang, Zhixiang
collection PubMed
description
format Online
Article
Text
id pubmed-7601148
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76011482020-11-01 Drug Resistance and Novel Therapies in Cancers Wang, Zhixiang Cancers (Basel) Editorial MDPI 2020-10-12 /pmc/articles/PMC7601148/ /pubmed/33053621 http://dx.doi.org/10.3390/cancers12102929 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Wang, Zhixiang
Drug Resistance and Novel Therapies in Cancers
title Drug Resistance and Novel Therapies in Cancers
title_full Drug Resistance and Novel Therapies in Cancers
title_fullStr Drug Resistance and Novel Therapies in Cancers
title_full_unstemmed Drug Resistance and Novel Therapies in Cancers
title_short Drug Resistance and Novel Therapies in Cancers
title_sort drug resistance and novel therapies in cancers
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601148/
https://www.ncbi.nlm.nih.gov/pubmed/33053621
http://dx.doi.org/10.3390/cancers12102929
work_keys_str_mv AT wangzhixiang drugresistanceandnoveltherapiesincancers